F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

F18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to investigate the role of tumor metabolic activity and its suppression by therapy for cancer survival. As part of Total Therapy 3 for newly diagnosed multiple myeloma, metastatic bone survey, magnetic resonance imaging...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bartel, Twyla B., Haessler, Jeff, Brown, Tracy L. Y., Shaughnessy, John D., van Rhee, Frits, Anaissie, Elias, Alpe, Terri, Angtuaco, Edgardo, Walker, Ronald, Epstein, Joshua, Crowley, John, Barlogie, Bart
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744568/
https://ncbi.nlm.nih.gov/pubmed/19443657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-213280
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados